Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „overall“
Suchtreffer
Begriffe & Kennungen
Akeega · 4.8 · Hepatotoxicity The overall incidence of hepatotoxicity was similar for the niraparib plus AAP (13.6%) and plac
Eintrag öffnenAkeega · 4.8 · Summary of the safety profile The overall safety profile of Akeega is based on pooled data from two clinical P
Eintrag öffnenAlhemo · 4.8 · The overall safety profile of concizumab is based on data from clinical trials. The most serious adverse react
Eintrag öffnenAlymsys · 4.8 · In clinical trials across all indications the overall incidence of NCI-CTCAE v.3 grade 3-5 bleeding reactions
Eintrag öffnenAlymsys · 4.8 · In clinical trials across indications, the overall incidence of venous thromboembolic reactions ranged from 2.
Eintrag öffnenAlymsys · 4.8 · In clinical trials, the overall incidence of arterial thromboembolic reactions ranged up to 3.8% in the bevaci
Eintrag öffnenAlymsys · 4.8 · In clinical trials, with the exception of study JO25567, the overall incidence of hypertension (all grades) ra
Eintrag öffnenAlymsys · 4.8 · The overall safety profile of bevacizumab is based on data from over 5,700 patients with various malignancies,
Eintrag öffnenApixaban Accord · 4.8 · 13 In the VTEt studies, the overall incidence of adverse reactions related to bleeding with apixaban was 15.6%
Eintrag öffnenApixaban Accord · 4.8 · In the NVAF studies, the overall incidence of adverse reactions related to bleeding with apixaban was 24.3% in
Eintrag öffnenApixaban Accord · 4.8 · In the NVAF studies, the overall incidence of adverse reactions related to bleeding with apixaban was 24.3% in
Eintrag öffnenApixaban Accord · 4.8 · In the VTEt studies, the overall incidence of adverse reactions related to bleeding with apixaban was 15.6% in
Eintrag öffnenApixaban Accord · 4.8 · Overall, the safety profile of apixaban in paediatric patients 28 days to < 18 years of age was similar to tha
Eintrag öffnenApixaban Accord · 4.8 · Overall, the safety profile of apixaban in paediatric patients 28 days to < 18 years of age was similar to tha
Eintrag öffnenAprovel · 4.8 · In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not di
Eintrag öffnenAprovel · 4.8 · In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not di
Eintrag öffnenAprovel · 4.8 · In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not di
Eintrag öffnenAprovel · 4.8 · In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not di
Eintrag öffnenAprovel · 4.8 · In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not di
Eintrag öffnenAprovel · 4.8 · In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not di
Eintrag öffnen